653-03-2|Butaperazine|1-Butanone, 1-(10-(3-(4-methyl-1-piperazinyl)propyl)-10H-phenothiazin-2-yl)-|-范德生物科技公司

Butaperazine

NMR下载 COA and HPLC MSDS下载
names：
1-Butanone, 1-(10-(3-(4-methyl-1-piperazinyl)propyl)-10H-phenothiazin-2-yl)-
CAS号：
653-03-2
MDL Number：
MF(分子式)： C24H31N33OS MW(分子量)： 409.59
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Butaperazine
英文别名	Butaperazine; Bayer 1362; Butaperazina; Butyrylperazine; Butyrylyperazine
CAS号	653-03-2
Inchi	InChI=1S/C24H31N3OS/c1-3-7-22(28)19-10-11-24-21(18-19)27(20-8-4-5-9-23(20)29-24)13-6-12-26-16-14-25(2)15-17-26/h4-5,8-11,18H,3,6-7,12-17H2,1-2H3
InchiKey	DVLBYTMYSMAKHP-UHFFFAOYSA-N
分子式 Formula	C24H31N33OS
分子量 Molecular Weight	409.59
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Butaperazine(CAS:653-03-2):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Butaperazine (Repoise, Tyrylen) is a typical antipsychotic of the phenothiazine class.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Samara MT, Cao H, Helfer B, Davis JM, Leucht S. Chlorpromazine versus every other antipsychotic for schizophrenia: a systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs. Eur Neuropsychopharmacol. 2014 Jul;24(7):1046-55. doi: 10.1016/j.euroneuro.2014.03.012. Epub 2014 Apr 4. Review. PubMed PMID: 24766970.

[2]Masti SP, Seetharamappa J, Melwanki MB, Motohashi N. Spectrophotometric determination of cerium(IV) using a phenothiazine derivative. Anal Sci. 2002 Feb;18(2):167-9. PubMed PMID: 11874120.

[3] Melwanki MB, Seetharamappa J, Masti SP. Spectrophotometric determination of vanadium(V) in minerals, steels, soil and biological samples using phenothiazine derivatives. Anal Sci. 2001 Aug;17(8):979-82. PubMed PMID: 11708104.

[4] Wenzel U, Bekemeier H. [Automatic, electronic determination of resting time in small laboratory animals and the effect of psychopharmaceuticals]. Pharmazie. 1991 Jul;46(7):528-30. German. PubMed PMID: 1784614.

[5] Mosnaim AD, Wolf ME. Administration of butaperazine and plasma methionine-enkephalin levels in schizophrenic and affective disorder patients with tardive dyskinesia. J Clin Psychopharmacol. 1988 Aug;8(4 Suppl):27S-30S. PubMed PMID: 2906066.

6: Rockland LH. Neuroleptic blood levels and clinical response. Can J Psychiatry. 1986 May;31(4):299-303. PubMed PMID: 2871920.7: Hergert I, Hecht HF, Peinhardt G. [Butaperazine blood level determination by radioimmunoassay following oral application of Tyrylen drug forms]. Pharmazie. 1986 Apr;41(4):289. German. PubMed PMID: 2873598.8: Oelssner W Jr, Peinhardt G, Büge A. [The affinity of aromatic fluoride derivatives of phenothiazine neuroleptics to spiroperidol binding sites of dopamine receptors by the radioligand technic in vitro]. Pharmazie. 1985 May;40(5):341-2. German. PubMed PMID: 2863832.9: Simpson GM, Yadalam K. Blood levels of neuroleptics: state of the art. J Clin Psychiatry. 1985 May;46(5 Pt 2):22-8. Review. PubMed PMID: 2859277.10: Wolf ME, Javaid JI, Mosnaim AD, Davis JM. Butaperazine pharmacokinetics in tardive dyskinesia. Biopharm Drug Dispos. 1985 Apr-Jun;6(2):223-7. PubMed PMID: 2860932.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开